News Backers submit plans for £1bn cancer district in London A planning application has been filed to invest £1bn in "the world's leading centre for cancer research and treatment" in a London borough.
News Granite Bio makes $100m debut, and other bio financings Our round-up of recent biotech financings includes rounds for Granite Bio, Biolinq, Etiome, Grove Biopharma, and Synthetic Design Lab.
News Merida raises $121m for Graves drug, and other financings Our round-up of recent biotech financings includes rounds for Merida, Glycomine, Attovia, Imbria, and Solu Therapeutics.
News Report says US biotech needs $15bn support to fend off China The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.
News MoonLake secures $500m for lead drug, plus other financings MoonLake secures $500m in financing for lead inflammatory disease drug sonelokimab while AIRNA, Atsena, and Neurona complete $100m+ private rounds.
News First gene-edited pig liver transplant 'worked for 10 days' In a xenotransplant milestone, scientists have carried out the first transplant of a genetically modified pig liver into a brain-dead human patient.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.